GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance

$472,650
Keith Syson Chan · Cedars-Sinai Medical Center · R01 · FY2021 · CA

Combination Therapy for Pancreatic Cancer

$472,623
Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Combination Therapy for Pancreatic Cancer

$472,623
Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

WASp signaling in T-cell lymphomas

$472,493
Carlos A. Murga-Zamalloa · University Of Illinois At Chicago · R01 · FY2025 · CA

DEVELOPMENTAL FUNDS

$472,450
Paul A Bunn · University Of Colorado Denver · P30 · FY2012 · CA

3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma

$472,438
Daniel Pelaez · University Of Miami School Of Medicine · R01 · FY2022 · CA

Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy

$472,355
Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA

Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy

$472,355
Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA

Hyaluronan Receptors in Prostate Cancer Progression

$472,331
James B. McCarthy · University Of Minnesota · R01 · FY2011 · CA

Core 3: Mouse Models Core (MM Core)

$472,258
Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2024 · CA

PET Imaging of Cancer with pH (Low) Insertion Peptide (pHLIP)

$472,174
Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA

Deciphering TREM1/2 Function in Primary Brain Cancer Using a New Model of Glioblastoma

$472,124
Alain Charest · Beth Israel Deaconess Medical Center · R21 · FY2024 · NS

The function of the PRMT5 methylosome in MTAP deleted cancers

$472,119
William R Sellers · Broad Institute, Inc. · R01 · FY2025 · CA

Mechanisms of Biguanide Sensitivity in GBM

$472,108
Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · NS

Image-guided radiation-induced permeability (IGRIP) for IGDD

$472,098
Stephen J. Kron · University Of Chicago · R01 · FY2019 · CA

Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer

$472,040
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA

Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer

$472,040
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA

Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer

$472,040
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA

Type A CCK Receptor Structure Function and Regulation

$472,003
Laurence J Miller · Mayo Clinic Arizona · R37 · FY2006 · DK

Targeting Neoantigens in Glioblastoma

$471,961
Gavin Peter Dunn · Washington University · R01 · FY2020 · NS

High Speed, High Resolution Slide Scanner for Research in Translational Medicine

$471,886
John S Condeelis · Albert Einstein College Of Medicine · S10 · FY2022 · OD

B7-H1/PD-1 modulation in cancer therapy

$471,842
Drew M. Pardoll · Johns Hopkins University · R01 · FY2012 · CA

Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer

$471,827
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer

$471,827
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC

$471,791
Judith A. Varner · University Of California, San Diego · R01 · FY2020 · CA